Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma

Sponsor
Children's Oncology Group (Other)
Overall Status
Unknown status
CT.gov ID
NCT00134030
Collaborator
National Cancer Institute (NCI) (NIH), University College London Hospitals (Other)
1,164
218
4
5.3

Study Details

Study Description

Brief Summary

This randomized phase III trial is studying combination chemotherapy followed by surgery and two different combination chemotherapy regimens with or without PEG-interferon alfa-2b to compare how well they work in treating patients with osteosarcoma. Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. Biological therapies, such as PEG-interferon alfa-2b, may interfere with the growth of tumor cells. Giving combination chemotherapy before surgery may shrink the tumor so it can be removed. Giving combination chemotherapy together with PEG-interferon alfa-2b after surgery may kill any remaining tumor cells. It is not yet known whether giving combination therapy together with PEG-interferon alfa-2b is more effective than two different combination chemotherapy regimens alone after surgery in treating osteosarcoma.

Condition or Disease Intervention/Treatment Phase
Phase 3

Detailed Description

PRIMARY OBJECTIVES:
  1. Compare whether adjuvant maintenance therapy comprising doxorubicin, cisplatin, and high-dose methotrexate (MAP) alone vs MAP combined with ifosfamide and etoposide improves event-free survival of patients with resectable high-grade osteosarcoma who achieve a poor histological response (HR) to neoadjuvant induction therapy comprising MAP.

  2. Compare whether adjuvant maintenance therapy comprising MAP alone vs MAP and PEG-interferon alfa-2b improves event-free survival of patients with resectable high-grade osteosarcoma who achieve a good HR to neoadjuvant induction therapy comprising MAP.

SECONDARY OBJECTIVES:
  1. Compare overall survival of patients treated with these regimens. II. Compare short- and long-term toxicity of these regimens in these patients. III. Compare quality of life of patients treated with these regimens. IV. Compare event-free survival and overall survival of patients with localized osteosarcoma treated with these regimens.

  2. Correlate biological or clinical changes with histological response and outcomes in patients treated with these regimens.

  3. Determine outcomes of patients treated with these regimens.

OUTLINE: This is a randomized, controlled, multicenter study.

INDUCTION THERAPY: (MAP; weeks 1-10) Patients receive doxorubicin IV continuously over 48 hours on days 1-2 and cisplatin IV over 4 hours on days 1 and 2 in weeks 1 and 6. Patients also receive high-dose methotrexate (MTX)* IV over 4 hours on day 1 in weeks 4, 5, 9, and 10. Patients then proceed to surgery.

NOTE: *Patients must receive >= 2 but =< 6 doses of high-dose MTX.

SURGERY: Patients undergo amputation or limb salvage surgery in week 11. Tumor tissue is evaluated for histological response to induction therapy. Patients whose tumor is not amenable to macroscopically complete surgical resection undergo radiotherapy and/or other investigational therapy off study. Patients who undergo macroscopically complete surgical resection of the primary tumor or metastases AND who have no disease progression or unacceptable toxicity proceed to maintenance therapy.

MAINTENANCE THERAPY: Patients are assigned to 1 of 2 groups according to histological response (good [< 10% viable tumor] vs poor [? 10% viable tumor]). Patients in each group are stratified according to site of primary tumor and presence of metastases.

GROUP 1: (good histological response) Patient are randomized to 1 of 2 treatment arms within 35 days after surgery.

ARM I: (MAP; weeks 12-29) Patients receive doxorubicin IV continuously over 48 hours on days 1-2 in weeks 12, 17, 22, and 26 and cisplatin IV over 4 hours on days 1 and 2 in weeks 12 and 17. Patients also receive high-dose MTX IV over 4 hours on day 1 in weeks 15, 16, 20, 21, 24, 25, 28, and 29.

ARM II: (MAPifn; weeks 12-104) Patients receive doxorubicin, cisplatin, and high-dose MTX as in arm I. Patients than receive PEG-interferon alfa-2b subcutaneously once daily on day 1 in weeks 30-104.

GROUP 2: (poor histological response) Patients are randomized to 1 of 2 treatment arms within 35 days after surgery.

ARM I: (MAP; weeks 12-29) Patients receive doxorubicin, cisplatin, and high-dose MTX as in group 1 arm I.

ARM II: (MAPIE; weeks 12-40) Patients receive doxorubicin IV continuously over 48 hours on days 1-2 in weeks 12, 20, 28, and 36 and cisplatin IV over 4 hours on days 1 and 2 in weeks 12 and 28. Patients also receive high-dose MTX IV over 4 hours on day 1 in weeks 15, 19, 23, 27, 31, 35, 39, and 40. Patients receive ifosfamide IV over 4 hours on days 1-5 in weeks 16, 24, and 32 and on days 1-3 in weeks 20 and 36 and etoposide IV over 1 hour on days 1-5 in weeks 16, 24, and 32.

In both groups, treatment continues in the absence of disease progression or unacceptable toxicity. Quality of life is assessed periodically.

After completion of study treatment, patients are followed every 1?-3 months for 2 years, every 2-4 months for 2 years, every 6 months for 6 years, and then every 6-12 months thereafter. Peer Reviewed and Funded or Endorsed by Cancer Research UK

Study Design

Study Type:
Interventional
Actual Enrollment :
1164 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Randomized Trial of the European and American Osteosarcoma Study Group to Optimize Treatment Strategies for Resectable Osteosarcoma Based on Histological Response to Pre-operative Chemotherapy
Actual Study Start Date :
Nov 14, 2005
Actual Primary Completion Date :
Jan 31, 2015

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Maintenance therapy group 1 arm I

Patients receive doxorubicin IV continuously over 48 hours on days 1-2 in weeks 12, 17, 22, and 26 and cisplatin IV over 4 hours on days 1 and 2 in weeks 12 and 17. Patients also receive high-dose MTX IV over 4 hours on day 1 in weeks 15, 16, 20, 21, 24, 25, 28, and 29.

Drug: Cisplatin
Given IV
Other Names:
  • Abiplatin
  • Blastolem
  • Briplatin
  • CDDP
  • Cis-diammine-dichloroplatinum
  • Cis-diamminedichloridoplatinum
  • Cis-diamminedichloro Platinum (II)
  • Cis-diamminedichloroplatinum
  • Cis-dichloroammine Platinum (II)
  • Cis-platinous Diamine Dichloride
  • Cis-platinum
  • Cis-platinum II
  • Cis-platinum II Diamine Dichloride
  • Cismaplat
  • Cisplatina
  • Cisplatinum
  • Cisplatyl
  • Citoplatino
  • Citosin
  • Cysplatyna
  • DDP
  • Lederplatin
  • Metaplatin
  • Neoplatin
  • Peyrone's Chloride
  • Peyrone's Salt
  • Placis
  • Plastistil
  • Platamine
  • Platiblastin
  • Platiblastin-S
  • Platinex
  • Platinol
  • Platinol- AQ
  • Platinol-AQ
  • Platinol-AQ VHA Plus
  • Platinoxan
  • Platinum
  • Platinum Diamminodichloride
  • Platiran
  • Platistin
  • Platosin
  • Drug: Doxorubicin Hydrochloride
    Given IV
    Other Names:
  • 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8, 9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)- (9CI)
  • ADM
  • Adriacin
  • Adriamycin
  • Adriamycin Hydrochloride
  • Adriamycin PFS
  • Adriamycin RDF
  • ADRIAMYCIN, HYDROCHLORIDE
  • Adriamycine
  • Adriblastina
  • Adriblastine
  • Adrimedac
  • Chloridrato de Doxorrubicina
  • DOX
  • DOXO-CELL
  • Doxolem
  • Doxorubicin.HCl
  • Doxorubin
  • Farmiblastina
  • FI 106
  • FI-106
  • hydroxydaunorubicin
  • Rubex
  • Drug: Methotrexate
    Given IV
    Other Names:
  • Abitrexate
  • Alpha-Methopterin
  • Amethopterin
  • Brimexate
  • CL 14377
  • CL-14377
  • Emtexate
  • Emthexat
  • Emthexate
  • Farmitrexat
  • Fauldexato
  • Folex
  • Folex PFS
  • Lantarel
  • Ledertrexate
  • Lumexon
  • Maxtrex
  • Medsatrexate
  • Metex
  • Methoblastin
  • Methotrexate LPF
  • Methotrexate Methylaminopterin
  • Methotrexatum
  • Metotrexato
  • Metrotex
  • Mexate
  • Mexate-AQ
  • MTX
  • Novatrex
  • Rheumatrex
  • Texate
  • Tremetex
  • Trexeron
  • Trixilem
  • WR-19039
  • Other: Quality-of-Life Assessment
    Ancillary studies
    Other Names:
  • Quality of Life Assessment
  • Other: Questionnaire Administration
    Ancillary studies

    Procedure: Therapeutic Conventional Surgery
    Undergo amputation or limb salvage surgery

    Experimental: Maintenance therapy group 1 arm II

    Patients receive doxorubicin, cisplatin, and high-dose MTX as in arm I. Patients than receive PEG-interferon alfa-2b subcutaneously once daily on day 1 in weeks 30-104.

    Drug: Cisplatin
    Given IV
    Other Names:
  • Abiplatin
  • Blastolem
  • Briplatin
  • CDDP
  • Cis-diammine-dichloroplatinum
  • Cis-diamminedichloridoplatinum
  • Cis-diamminedichloro Platinum (II)
  • Cis-diamminedichloroplatinum
  • Cis-dichloroammine Platinum (II)
  • Cis-platinous Diamine Dichloride
  • Cis-platinum
  • Cis-platinum II
  • Cis-platinum II Diamine Dichloride
  • Cismaplat
  • Cisplatina
  • Cisplatinum
  • Cisplatyl
  • Citoplatino
  • Citosin
  • Cysplatyna
  • DDP
  • Lederplatin
  • Metaplatin
  • Neoplatin
  • Peyrone's Chloride
  • Peyrone's Salt
  • Placis
  • Plastistil
  • Platamine
  • Platiblastin
  • Platiblastin-S
  • Platinex
  • Platinol
  • Platinol- AQ
  • Platinol-AQ
  • Platinol-AQ VHA Plus
  • Platinoxan
  • Platinum
  • Platinum Diamminodichloride
  • Platiran
  • Platistin
  • Platosin
  • Drug: Doxorubicin Hydrochloride
    Given IV
    Other Names:
  • 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8, 9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)- (9CI)
  • ADM
  • Adriacin
  • Adriamycin
  • Adriamycin Hydrochloride
  • Adriamycin PFS
  • Adriamycin RDF
  • ADRIAMYCIN, HYDROCHLORIDE
  • Adriamycine
  • Adriblastina
  • Adriblastine
  • Adrimedac
  • Chloridrato de Doxorrubicina
  • DOX
  • DOXO-CELL
  • Doxolem
  • Doxorubicin.HCl
  • Doxorubin
  • Farmiblastina
  • FI 106
  • FI-106
  • hydroxydaunorubicin
  • Rubex
  • Drug: Methotrexate
    Given IV
    Other Names:
  • Abitrexate
  • Alpha-Methopterin
  • Amethopterin
  • Brimexate
  • CL 14377
  • CL-14377
  • Emtexate
  • Emthexat
  • Emthexate
  • Farmitrexat
  • Fauldexato
  • Folex
  • Folex PFS
  • Lantarel
  • Ledertrexate
  • Lumexon
  • Maxtrex
  • Medsatrexate
  • Metex
  • Methoblastin
  • Methotrexate LPF
  • Methotrexate Methylaminopterin
  • Methotrexatum
  • Metotrexato
  • Metrotex
  • Mexate
  • Mexate-AQ
  • MTX
  • Novatrex
  • Rheumatrex
  • Texate
  • Tremetex
  • Trexeron
  • Trixilem
  • WR-19039
  • Biological: Peginterferon Alfa-2b
    Given subcutaneously
    Other Names:
  • PEG Interferon Alpha-2b
  • PEG Intron
  • PEG-IFN Alfa-2b
  • PEG-IFN-a 2b
  • PEG-interferon alfa-2b
  • PEG-Intron
  • Pegylated Interferon Alpha-2b
  • Polyethylene Glycol IFN-A2b
  • Polyethylene Glycol Interferon Alfa-2b
  • SCH 54031
  • Sylatron
  • Other: Quality-of-Life Assessment
    Ancillary studies
    Other Names:
  • Quality of Life Assessment
  • Other: Questionnaire Administration
    Ancillary studies

    Procedure: Therapeutic Conventional Surgery
    Undergo amputation or limb salvage surgery

    Active Comparator: Maintenance therapy group 2 arm I

    Patients receive doxorubicin, cisplatin, and high-dose MTX as in group 1 arm I.

    Drug: Cisplatin
    Given IV
    Other Names:
  • Abiplatin
  • Blastolem
  • Briplatin
  • CDDP
  • Cis-diammine-dichloroplatinum
  • Cis-diamminedichloridoplatinum
  • Cis-diamminedichloro Platinum (II)
  • Cis-diamminedichloroplatinum
  • Cis-dichloroammine Platinum (II)
  • Cis-platinous Diamine Dichloride
  • Cis-platinum
  • Cis-platinum II
  • Cis-platinum II Diamine Dichloride
  • Cismaplat
  • Cisplatina
  • Cisplatinum
  • Cisplatyl
  • Citoplatino
  • Citosin
  • Cysplatyna
  • DDP
  • Lederplatin
  • Metaplatin
  • Neoplatin
  • Peyrone's Chloride
  • Peyrone's Salt
  • Placis
  • Plastistil
  • Platamine
  • Platiblastin
  • Platiblastin-S
  • Platinex
  • Platinol
  • Platinol- AQ
  • Platinol-AQ
  • Platinol-AQ VHA Plus
  • Platinoxan
  • Platinum
  • Platinum Diamminodichloride
  • Platiran
  • Platistin
  • Platosin
  • Drug: Doxorubicin Hydrochloride
    Given IV
    Other Names:
  • 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8, 9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)- (9CI)
  • ADM
  • Adriacin
  • Adriamycin
  • Adriamycin Hydrochloride
  • Adriamycin PFS
  • Adriamycin RDF
  • ADRIAMYCIN, HYDROCHLORIDE
  • Adriamycine
  • Adriblastina
  • Adriblastine
  • Adrimedac
  • Chloridrato de Doxorrubicina
  • DOX
  • DOXO-CELL
  • Doxolem
  • Doxorubicin.HCl
  • Doxorubin
  • Farmiblastina
  • FI 106
  • FI-106
  • hydroxydaunorubicin
  • Rubex
  • Drug: Methotrexate
    Given IV
    Other Names:
  • Abitrexate
  • Alpha-Methopterin
  • Amethopterin
  • Brimexate
  • CL 14377
  • CL-14377
  • Emtexate
  • Emthexat
  • Emthexate
  • Farmitrexat
  • Fauldexato
  • Folex
  • Folex PFS
  • Lantarel
  • Ledertrexate
  • Lumexon
  • Maxtrex
  • Medsatrexate
  • Metex
  • Methoblastin
  • Methotrexate LPF
  • Methotrexate Methylaminopterin
  • Methotrexatum
  • Metotrexato
  • Metrotex
  • Mexate
  • Mexate-AQ
  • MTX
  • Novatrex
  • Rheumatrex
  • Texate
  • Tremetex
  • Trexeron
  • Trixilem
  • WR-19039
  • Other: Quality-of-Life Assessment
    Ancillary studies
    Other Names:
  • Quality of Life Assessment
  • Other: Questionnaire Administration
    Ancillary studies

    Procedure: Therapeutic Conventional Surgery
    Undergo amputation or limb salvage surgery

    Experimental: Maintenance therapy group 2 arm II

    Patients receive doxorubicin IV continuously over 48 hours on days 1-2 in weeks 12, 20, 28, and 36 and cisplatin IV over 4 hours on days 1 and 2 in weeks 12 and 28. Patients also receive high-dose MTX IV over 4 hours on day 1 in weeks 15, 19, 23, 27, 31, 35, 39, and 40. Patients receive ifosfamide IV over 4 hours on days 1-5 in weeks 16, 24, and 32 and on days 1-3 in weeks 20 and 36 and etoposide IV over 1 hour on days 1-5 in weeks 16, 24, and 32.

    Drug: Cisplatin
    Given IV
    Other Names:
  • Abiplatin
  • Blastolem
  • Briplatin
  • CDDP
  • Cis-diammine-dichloroplatinum
  • Cis-diamminedichloridoplatinum
  • Cis-diamminedichloro Platinum (II)
  • Cis-diamminedichloroplatinum
  • Cis-dichloroammine Platinum (II)
  • Cis-platinous Diamine Dichloride
  • Cis-platinum
  • Cis-platinum II
  • Cis-platinum II Diamine Dichloride
  • Cismaplat
  • Cisplatina
  • Cisplatinum
  • Cisplatyl
  • Citoplatino
  • Citosin
  • Cysplatyna
  • DDP
  • Lederplatin
  • Metaplatin
  • Neoplatin
  • Peyrone's Chloride
  • Peyrone's Salt
  • Placis
  • Plastistil
  • Platamine
  • Platiblastin
  • Platiblastin-S
  • Platinex
  • Platinol
  • Platinol- AQ
  • Platinol-AQ
  • Platinol-AQ VHA Plus
  • Platinoxan
  • Platinum
  • Platinum Diamminodichloride
  • Platiran
  • Platistin
  • Platosin
  • Drug: Doxorubicin Hydrochloride
    Given IV
    Other Names:
  • 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8, 9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)- (9CI)
  • ADM
  • Adriacin
  • Adriamycin
  • Adriamycin Hydrochloride
  • Adriamycin PFS
  • Adriamycin RDF
  • ADRIAMYCIN, HYDROCHLORIDE
  • Adriamycine
  • Adriblastina
  • Adriblastine
  • Adrimedac
  • Chloridrato de Doxorrubicina
  • DOX
  • DOXO-CELL
  • Doxolem
  • Doxorubicin.HCl
  • Doxorubin
  • Farmiblastina
  • FI 106
  • FI-106
  • hydroxydaunorubicin
  • Rubex
  • Drug: Etoposide
    Given IV
    Other Names:
  • Demethyl Epipodophyllotoxin Ethylidine Glucoside
  • EPEG
  • Lastet
  • Toposar
  • Vepesid
  • VP 16-213
  • VP-16
  • VP-16-213
  • Drug: Ifosfamide
    Given IV
    Other Names:
  • Asta Z 4942
  • Asta Z-4942
  • Cyfos
  • Holoxan
  • Holoxane
  • Ifex
  • IFO
  • IFO-Cell
  • Ifolem
  • Ifomida
  • Ifomide
  • Ifosfamidum
  • Ifoxan
  • IFX
  • Iphosphamid
  • Iphosphamide
  • Iso-Endoxan
  • Isoendoxan
  • Isophosphamide
  • Mitoxana
  • MJF 9325
  • MJF-9325
  • Naxamide
  • Seromida
  • Tronoxal
  • Z 4942
  • Z-4942
  • Drug: Methotrexate
    Given IV
    Other Names:
  • Abitrexate
  • Alpha-Methopterin
  • Amethopterin
  • Brimexate
  • CL 14377
  • CL-14377
  • Emtexate
  • Emthexat
  • Emthexate
  • Farmitrexat
  • Fauldexato
  • Folex
  • Folex PFS
  • Lantarel
  • Ledertrexate
  • Lumexon
  • Maxtrex
  • Medsatrexate
  • Metex
  • Methoblastin
  • Methotrexate LPF
  • Methotrexate Methylaminopterin
  • Methotrexatum
  • Metotrexato
  • Metrotex
  • Mexate
  • Mexate-AQ
  • MTX
  • Novatrex
  • Rheumatrex
  • Texate
  • Tremetex
  • Trexeron
  • Trixilem
  • WR-19039
  • Other: Quality-of-Life Assessment
    Ancillary studies
    Other Names:
  • Quality of Life Assessment
  • Other: Questionnaire Administration
    Ancillary studies

    Procedure: Therapeutic Conventional Surgery
    Undergo amputation or limb salvage surgery

    Outcome Measures

    Primary Outcome Measures

    1. Event-free survival [From date of randomization to date of the event, assessed up to 10 years]

      Will be assessed using the logrank test and expressed using hazard ratios with appropriate confidence intervals.

    Secondary Outcome Measures

    1. Overall survival [From date of randomization to date of death, assessed up to 10 years]

      Will be assessed using the logrank test and expressed using hazard ratios with appropriate confidence intervals.

    2. Toxicity as measured by CTCAE v3.0 [Up to 10 years]

      Proportions of patients experiencing grade 3 and 4 toxicities will be compared using chi-square tests or Fisher's exact tests where appropriate.

    3. Quality of life [Up to 3 years]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    5 Years to 40 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Histologically confirmed high-grade osteosarcoma, including second malignancies

    • Localized or metastatic disease

    • The primary tumor must be located in the limbs or axial skeleton, including any of the following sites*:

    • Long bone of upper limb

    • Short bone of upper limb

    • Long bone of lower limb

    • Short bone of lower limb

    • Vertebral column

    • Ribs, sternum, clavicle, or scapula

    • Pelvic bones, sacrum, or coccyx

    • Tumor (primary, metastatic, or both) resectable OR is expected to become resectable after neoadjuvant induction chemotherapy

    • Suitable for neoadjuvant chemotherapy

    • Performance status - Lansky 50-100% (for patients under 16 years of age)

    • Performance status - Karnofsky 50-100%*

    • Performance status - WHO or ECOG 0-2*

    • Platelet count ? 100,000/mm?

    • Neutrophil count ? 1,500/mm?

    • WBC ? 3,000/mm?

    • Bilirubin ? 1.5 times upper limit of normal

    • Creatinine clearance ? 70 mL/min

    • Creatinine based on age as follows:

    • No greater than 1.0 mg/dL (for patients 5 to 10 years of age)

    • No greater than 1.2 mg/dL (for patients 11 to 15 years of age)

    • No greater than 1.5 mg/dL (for patients over 15 years of age)

    • Ejection fraction ? 50% by radionuclide angiogram

    • Shortening fraction ? 28% by echocardiogram

    • Not pregnant or nursing

    • Negative pregnancy test

    • Fertile patients must use effective contraception

    • No known HIV positivity

    • No prior chemotherapy for any disease

    • Prior radiotherapy for another malignancy allowed

    • No prior treatment for osteosarcoma

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Children's Hospital of Alabama Birmingham Alabama United States 35233
    2 University of Alabama at Birmingham Cancer Center Birmingham Alabama United States 35233
    3 Phoenix Childrens Hospital Phoenix Arizona United States 85016
    4 The University of Arizona Medical Center-University Campus Tucson Arizona United States 85724
    5 Arkansas Children's Hospital Little Rock Arkansas United States 72202-3591
    6 University of Arkansas for Medical Sciences Little Rock Arkansas United States 72205
    7 Southern California Permanente Medical Group Downey California United States 90242
    8 City of Hope Comprehensive Cancer Center Duarte California United States 91010
    9 Loma Linda University Medical Center Loma Linda California United States 92354
    10 Miller Children's and Women's Hospital Long Beach Long Beach California United States 90806
    11 Children's Hospital Los Angeles Los Angeles California United States 90027
    12 Cedars Sinai Medical Center Los Angeles California United States 90048
    13 Mattel Children's Hospital UCLA Los Angeles California United States 90095
    14 UCLA / Jonsson Comprehensive Cancer Center Los Angeles California United States 90095
    15 Children's Hospital Central California Madera California United States 93636-8762
    16 Children's Hospital and Research Center at Oakland Oakland California United States 94609-1809
    17 Kaiser Permanente-Oakland Oakland California United States 94611
    18 Children's Hospital of Orange County Orange California United States 92868
    19 Lucile Packard Children's Hospital Stanford University Palo Alto California United States 94304
    20 Sutter Medical Center Sacramento Sacramento California United States 95816
    21 University of California Davis Comprehensive Cancer Center Sacramento California United States 95817
    22 Rady Children's Hospital - San Diego San Diego California United States 92123
    23 UCSF Medical Center-Mount Zion San Francisco California United States 94115
    24 UCSF Medical Center-Parnassus San Francisco California United States 94143
    25 UCSF Medical Center-Mission Bay San Francisco California United States 94158
    26 Harbor-University of California at Los Angeles Medical Center Torrance California United States 90502
    27 Children's Hospital Colorado Aurora Colorado United States 80045
    28 University of Connecticut Farmington Connecticut United States 06030
    29 Connecticut Children's Medical Center Hartford Connecticut United States 06106
    30 Yale University New Haven Connecticut United States 06520
    31 Alfred I duPont Hospital for Children Wilmington Delaware United States 19803
    32 MedStar Georgetown University Hospital Washington District of Columbia United States 20007
    33 Children's National Medical Center Washington District of Columbia United States 20010
    34 Broward Health Medical Center Fort Lauderdale Florida United States 33316
    35 Lee Memorial Health System Fort Myers Florida United States 33901
    36 Golisano Children's Hospital of Southwest Florida Fort Myers Florida United States 33908
    37 University of Florida Health Science Center - Gainesville Gainesville Florida United States 32610
    38 Memorial Regional Hospital/Joe DiMaggio Children's Hospital Hollywood Florida United States 33021
    39 Nemours Children's Clinic-Jacksonville Jacksonville Florida United States 32207
    40 University of Miami Miller School of Medicine-Sylvester Cancer Center Miami Florida United States 33136
    41 Miami Cancer Institute Miami Florida United States 33176
    42 Florida Hospital Orlando Orlando Florida United States 32803
    43 Arnold Palmer Hospital for Children Orlando Florida United States 32806
    44 Nemours Children's Clinic - Orlando Orlando Florida United States 32806
    45 UF Cancer Center at Orlando Health Orlando Florida United States 32806
    46 Nemours Children's Hospital Orlando Florida United States 32827
    47 Nemours Children's Clinic - Pensacola Pensacola Florida United States 32504
    48 Sacred Heart Hospital Pensacola Florida United States 32504
    49 Johns Hopkins All Children's Hospital Saint Petersburg Florida United States 33701
    50 Saint Joseph's Hospital/Children's Hospital-Tampa Tampa Florida United States 33607
    51 Children's Healthcare of Atlanta - Egleston Atlanta Georgia United States 30322
    52 Augusta University Medical Center Augusta Georgia United States 30912
    53 Memorial Health University Medical Center Savannah Georgia United States 31404
    54 University of Hawaii Cancer Center Honolulu Hawaii United States 96813
    55 Kapiolani Medical Center for Women and Children Honolulu Hawaii United States 96826
    56 Tripler Army Medical Center Honolulu Hawaii United States 96859
    57 Lurie Children's Hospital-Chicago Chicago Illinois United States 60611
    58 Rush University Medical Center Chicago Illinois United States 60612
    59 University of Illinois Chicago Illinois United States 60612
    60 Loyola University Medical Center Maywood Illinois United States 60153
    61 Advocate Children's Hospital-Oak Lawn Oak Lawn Illinois United States 60453
    62 Saint Jude Midwest Affiliate Peoria Illinois United States 61637
    63 Southern Illinois University School of Medicine Springfield Illinois United States 62702
    64 Indiana University/Melvin and Bren Simon Cancer Center Indianapolis Indiana United States 46202
    65 Riley Hospital for Children Indianapolis Indiana United States 46202
    66 Saint Vincent Hospital and Health Care Center Indianapolis Indiana United States 46260
    67 Blank Children's Hospital Des Moines Iowa United States 50309
    68 University of Iowa/Holden Comprehensive Cancer Center Iowa City Iowa United States 52242
    69 University of Kansas Cancer Center Kansas City Kansas United States 66160
    70 University of Kentucky/Markey Cancer Center Lexington Kentucky United States 40536
    71 Norton Children's Hospital Louisville Kentucky United States 40202
    72 Tulane University Health Sciences Center New Orleans Louisiana United States 70112
    73 Children's Hospital New Orleans New Orleans Louisiana United States 70118
    74 Ochsner Medical Center Jefferson New Orleans Louisiana United States 70121
    75 Eastern Maine Medical Center Bangor Maine United States 04401
    76 Maine Children's Cancer Program Scarborough Maine United States 04074
    77 Sinai Hospital of Baltimore Baltimore Maryland United States 21215
    78 Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore Maryland United States 21287
    79 Massachusetts General Hospital Cancer Center Boston Massachusetts United States 02114
    80 Dana-Farber Cancer Institute Boston Massachusetts United States 02215
    81 University of Massachusetts Medical School Worcester Massachusetts United States 01655
    82 C S Mott Children's Hospital Ann Arbor Michigan United States 48109
    83 Wayne State University/Karmanos Cancer Institute Detroit Michigan United States 48201
    84 Saint John Hospital and Medical Center Detroit Michigan United States 48236
    85 Michigan State University Clinical Center East Lansing Michigan United States 48824-7016
    86 Hurley Medical Center Flint Michigan United States 48503
    87 Helen DeVos Children's Hospital at Spectrum Health Grand Rapids Michigan United States 49503
    88 Spectrum Health at Butterworth Campus Grand Rapids Michigan United States 49503
    89 Bronson Methodist Hospital Kalamazoo Michigan United States 49007
    90 Kalamazoo Center for Medical Studies Kalamazoo Michigan United States 49008
    91 Beaumont Children's Hospital-Royal Oak Royal Oak Michigan United States 48073
    92 William Beaumont Hospital-Royal Oak Royal Oak Michigan United States 48073
    93 Children's Hospitals and Clinics of Minnesota - Minneapolis Minneapolis Minnesota United States 55404
    94 University of Minnesota/Masonic Cancer Center Minneapolis Minnesota United States 55455
    95 Mayo Clinic Rochester Minnesota United States 55905
    96 University of Mississippi Medical Center Jackson Mississippi United States 39216
    97 The Childrens Mercy Hospital Kansas City Missouri United States 64108
    98 Cardinal Glennon Children's Medical Center Saint Louis Missouri United States 63104
    99 Washington University School of Medicine Saint Louis Missouri United States 63110
    100 Children's Hospital and Medical Center of Omaha Omaha Nebraska United States 68114
    101 University of Nebraska Medical Center Omaha Nebraska United States 68198
    102 Nevada Cancer Research Foundation CCOP Las Vegas Nevada United States 89106
    103 Children's Specialty Center of Nevada II Las Vegas Nevada United States 89109
    104 Hackensack University Medical Center Hackensack New Jersey United States 07601
    105 Saint Barnabas Medical Center Livingston New Jersey United States 07039
    106 Morristown Medical Center Morristown New Jersey United States 07960
    107 Saint Peter's University Hospital New Brunswick New Jersey United States 08901
    108 Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital New Brunswick New Jersey United States 08903
    109 Newark Beth Israel Medical Center Newark New Jersey United States 07112
    110 Saint Joseph's Regional Medical Center Paterson New Jersey United States 07503
    111 Overlook Hospital Summit New Jersey United States 07902
    112 University of New Mexico Cancer Center Albuquerque New Mexico United States 87102
    113 Albany Medical Center Albany New York United States 12208
    114 Montefiore Medical Center - Moses Campus Bronx New York United States 10467
    115 Brooklyn Hospital Center Brooklyn New York United States 11201
    116 Roswell Park Cancer Institute Buffalo New York United States 14263
    117 The Steven and Alexandra Cohen Children's Medical Center of New York New Hyde Park New York United States 11040
    118 Laura and Isaac Perlmutter Cancer Center at NYU Langone New York New York United States 10016
    119 Mount Sinai Hospital New York New York United States 10029
    120 Columbia University/Herbert Irving Cancer Center New York New York United States 10032
    121 University of Rochester Rochester New York United States 14642
    122 State University of New York Upstate Medical University Syracuse New York United States 13210
    123 New York Medical College Valhalla New York United States 10595
    124 Mission Hospital-Memorial Campus Asheville North Carolina United States 28801
    125 UNC Lineberger Comprehensive Cancer Center Chapel Hill North Carolina United States 27599
    126 Carolinas Medical Center/Levine Cancer Institute Charlotte North Carolina United States 28203
    127 Novant Health Presbyterian Medical Center Charlotte North Carolina United States 28204
    128 Duke University Medical Center Durham North Carolina United States 27710
    129 East Carolina University Greenville North Carolina United States 27858
    130 Wake Forest University Health Sciences Winston-Salem North Carolina United States 27157
    131 Sanford Broadway Medical Center Fargo North Dakota United States 58122
    132 Children's Hospital Medical Center of Akron Akron Ohio United States 44308
    133 Cincinnati Children's Hospital Medical Center Cincinnati Ohio United States 45229
    134 Rainbow Babies and Childrens Hospital Cleveland Ohio United States 44106
    135 Cleveland Clinic Foundation Cleveland Ohio United States 44195
    136 Nationwide Children's Hospital Columbus Ohio United States 43205
    137 Dayton Children's Hospital Dayton Ohio United States 45404
    138 The Toledo Hospital/Toledo Children's Hospital Toledo Ohio United States 43606
    139 Mercy Children's Hospital Toledo Ohio United States 43608
    140 University of Toledo Toledo Ohio United States 43614
    141 University of Oklahoma Health Sciences Center Oklahoma City Oklahoma United States 73104
    142 Legacy Emanuel Children's Hospital Portland Oregon United States 97227
    143 Legacy Emanuel Hospital and Health Center Portland Oregon United States 97227
    144 Oregon Health and Science University Portland Oregon United States 97239
    145 Lehigh Valley Hospital - Muhlenberg Bethlehem Pennsylvania United States 18017
    146 Geisinger Medical Center Danville Pennsylvania United States 17822
    147 Penn State Milton S Hershey Medical Center Hershey Pennsylvania United States 17033-0850
    148 Penn State Children's Hospital Hershey Pennsylvania United States 17033
    149 Children's Hospital of Philadelphia Philadelphia Pennsylvania United States 19104
    150 Saint Christopher's Hospital for Children Philadelphia Pennsylvania United States 19134
    151 Children's Hospital of Pittsburgh of UPMC Pittsburgh Pennsylvania United States 15224
    152 Medical University of South Carolina Charleston South Carolina United States 29425
    153 Palmetto Health Richland Columbia South Carolina United States 29203
    154 BI-LO Charities Children's Cancer Center Greenville South Carolina United States 29605
    155 Greenville Cancer Treatment Center Greenville South Carolina United States 29605
    156 Sanford USD Medical Center - Sioux Falls Sioux Falls South Dakota United States 57117-5134
    157 T C Thompson Children's Hospital Chattanooga Tennessee United States 37403
    158 East Tennessee Childrens Hospital Knoxville Tennessee United States 37916
    159 Vanderbilt University/Ingram Cancer Center Nashville Tennessee United States 37232
    160 Texas Tech University Health Sciences Center-Amarillo Amarillo Texas United States 79106
    161 Driscoll Children's Hospital Corpus Christi Texas United States 78411
    162 Medical City Dallas Hospital Dallas Texas United States 75230
    163 UT Southwestern/Simmons Cancer Center-Dallas Dallas Texas United States 75390
    164 Cook Children's Medical Center Fort Worth Texas United States 76104
    165 Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center Houston Texas United States 77030
    166 M D Anderson Cancer Center Houston Texas United States 77030
    167 Methodist Children's Hospital of South Texas San Antonio Texas United States 78229
    168 University of Texas Health Science Center at San Antonio San Antonio Texas United States 78229
    169 Scott and White Memorial Hospital Temple Texas United States 76508
    170 Primary Children's Hospital Salt Lake City Utah United States 84113
    171 University of Vermont College of Medicine Burlington Vermont United States 05405
    172 University of Virginia Cancer Center Charlottesville Virginia United States 22908
    173 Inova Fairfax Hospital Falls Church Virginia United States 22042
    174 Childrens Hospital-King's Daughters Norfolk Virginia United States 23507
    175 Virginia Commonwealth University/Massey Cancer Center Richmond Virginia United States 23298
    176 Carilion Clinic Children's Hospital Roanoke Virginia United States 24014
    177 Seattle Children's Hospital Seattle Washington United States 98105
    178 Providence Sacred Heart Medical Center and Children's Hospital Spokane Washington United States 99204
    179 Mary Bridge Children's Hospital and Health Center Tacoma Washington United States 98405
    180 Madigan Army Medical Center Tacoma Washington United States 98431
    181 West Virginia University Charleston Division Charleston West Virginia United States 25304
    182 Cabell-Huntington Hospital Huntington West Virginia United States 25701
    183 Saint Vincent Hospital Cancer Center Green Bay Green Bay Wisconsin United States 54301
    184 University of Wisconsin Hospital and Clinics Madison Wisconsin United States 53792
    185 Marshfield Clinic Marshfield Wisconsin United States 54449
    186 Children's Hospital of Wisconsin Milwaukee Wisconsin United States 53226
    187 John Hunter Children's Hospital Hunter Regional Mail Centre New South Wales Australia 2310
    188 The Children's Hospital at Westmead Westmead New South Wales Australia 2145
    189 Westmead Hospital Westmead New South Wales Australia 2145
    190 Royal Brisbane and Women's Hospital Herston Queensland Australia 4029
    191 Royal Children's Hospital-Brisbane Herston Queensland Australia 4029
    192 Lady Cilento Children's Hospital South Brisbane Queensland Australia 4101
    193 Women's and Children's Hospital-Adelaide North Adelaide South Australia Australia 5006
    194 Royal Children's Hospital Parkville Victoria Australia 3052
    195 Princess Margaret Hospital for Children Perth Western Australia Australia 6008
    196 Alberta Children's Hospital Calgary Alberta Canada T3B 6A8
    197 University of Alberta Hospital Edmonton Alberta Canada T6G 2B7
    198 British Columbia Children's Hospital Vancouver British Columbia Canada V6H 3V4
    199 CancerCare Manitoba Winnipeg Manitoba Canada R3E 0V9
    200 Janeway Child Health Centre Saint John's Newfoundland and Labrador Canada A1B 3V6
    201 IWK Health Centre Halifax Nova Scotia Canada B3K 6R8
    202 McMaster Children's Hospital at Hamilton Health Sciences Hamilton Ontario Canada L8N 3Z5
    203 Kingston Health Sciences Centre Kingston Ontario Canada K7L 2V7
    204 Children's Hospital London Ontario Canada N6A 5W9
    205 Victoria Hospital London Ontario Canada N6K 1C2
    206 Children's Hospital of Eastern Ontario Ottawa Ontario Canada K1H 8L1
    207 Hospital for Sick Children Toronto Ontario Canada M5G 1X8
    208 The Montreal Children's Hospital of the MUHC Montreal Quebec Canada H3H 1P3
    209 Centre Hospitalier Universitaire Sainte-Justine Montreal Quebec Canada H3T 1C5
    210 Saskatoon Cancer Centre Saskatoon Saskatchewan Canada S7N 4H4
    211 Centre Hospitalier Universitaire de Quebec Quebec Canada G1V 4G2
    212 Starship Children's Hospital Grafton Auckland New Zealand 1145
    213 Christchurch Hospital Christchurch New Zealand 8011
    214 Wellington Children's Hospital Wellington New Zealand 6002
    215 San Jorge Children's Hospital San Juan Puerto Rico 00912
    216 Swiss Pediatric Oncology Group - Bern Bern Switzerland 3010
    217 Swiss Pediatric Oncology Group - Geneva Geneva Switzerland 1205
    218 Swiss Pediatric Oncology Group - Lausanne Lausanne Switzerland 1011

    Sponsors and Collaborators

    • Children's Oncology Group
    • National Cancer Institute (NCI)
    • University College London Hospitals

    Investigators

    • Principal Investigator: Neyssa Marina, Children's Oncology Group

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Children's Oncology Group
    ClinicalTrials.gov Identifier:
    NCT00134030
    Other Study ID Numbers:
    • AOST0331
    • NCI-2009-01066
    • EUDRACT-2004-000242-20
    • MRC-EURAMOS1
    • EU-20530
    • ISRCTN67613327
    • MRC-BO08
    • 06-93
    • CDR0000438714
    • COG-AOST0331
    • AOST0331
    • AOST0331
    • U10CA180886
    • U10CA098543
    First Posted:
    Aug 24, 2005
    Last Update Posted:
    Jun 8, 2018
    Last Verified:
    Jun 1, 2018

    Study Results

    No Results Posted as of Jun 8, 2018